Positive Inotropic drugs in the treatment of Heart Failure

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment of Pharmacologyhu_HU
dc.contributor.authorSofimieari, Tamunonengiyeofori
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Aneszteziológiai és Intenzív Terápiás Tanszékhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-18T09:14:59Z
dc.date.available2022-08-18T09:14:59Z
dc.date.created2022-08-17
dc.description.abstractPositive Inotropic Drugs are drugs that work by increasing the strength of the heart contraction.They are used in conditions where the heart cannot pump enough blood to the rest of the body like in systolic Heart Failure. The most common cause of systolic Heart failure is ischemic heart disease.Some examples of positive inotropes are cardiac glycosides,phosphodiesterase inhibitors,dobutamine, dopamine and norepinephrine.These drugs lead to the increase in stroke volume and cardiac output. Positive Inotropes should be avoided in ventricular outflow obstruction because it can lead to further deterioration of the patients case.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent48 pageshu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336586
dc.language.isoenhu_HU
dc.subjectheart failurehu_HU
dc.subjectinotropeshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePositive Inotropic drugs in the treatment of Heart Failurehu_HU
Fájlok